$886M Otsuka Buyout Cheats Astex Investors, Suit Says
An Astex Pharmaceuticals Inc. investor launched a putative class action Wednesday aimed at blocking its planned $886 million buyout by Japanese drugmaker Otsuka Holdings Co. Ltd., saying the deal shortchanges shareholders...To view the full article, register now.
Already a subscriber? Click here to view full article